🇺🇸 FDA
Patent

US 8785486

Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

granted A61PA61P1/08A61P13/00

Quick answer

US patent 8785486 (Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors) held by Addex Pharma, S.A. expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/08, A61P13/00, A61P21/02, A61P25/00